Today: 26 April 2026
Mortgage rates today slip back into the 5s as Treasuries firm; Rocket Mortgage stock slides
23 February 2026
2 mins read

Mortgage rates today slip back into the 5s as Treasuries firm; Rocket Mortgage stock slides

New York, Feb 23, 2026, 14:25 EST — Regular session

  • Bonds rallied, pulling the benchmark 30-year fixed mortgage rate back under 6%.
  • Mortgage lenders and homebuilders dropped as U.S. equities took on a risk-off tone.
  • Eyes are on consumer confidence data, with Fed speakers also in focus as traders gauge the direction for rates.

Mortgage rates slid back into the 5% territory as the average top-tier 30-year fixed dropped to 5.99%, down roughly 5 basis points from Friday, according to Mortgage News Daily. Matthew Graham, the publication’s author, noted there’s “no new news causing the improvement,” but flagged the risk that lenders may reprice swiftly if bonds head the other way. Mortgage News Daily

This is shaping up to be a key stretch for the housing market, with spring’s selling rush approaching and borrowing costs still carrying much of the weight on demand. A steady dip under 6% could ease monthly payments for buyers, and might finally pull some sidelined refinancers back into the mix.

The impact lands directly on what mortgage lenders and homebuilders are watching. When rates drop, buying can pick up and the pain from rate locks eases. But it’s not just the destination — how rates move counts. A sudden move in a single day? Lender pricing gets jumpy, and demand doesn’t respond cleanly.

Another daily reading delivered a similar signal. NerdWallet, using Zillow’s rate data, pegged the average 30-year fixed mortgage at 5.88% APR on Monday—a 4 basis-point dip from Friday’s level. APR, which folds in the rate plus select lender fees, allows for direct loan comparisons.

Treasury yields slipped, with investors wrestling over the implications of a Supreme Court decision that overturned President Donald Trump’s earlier tariffs. The move left markets uncertain about potential refunds and new tariffs. According to Reuters data, benchmark 10-year yields hovered around 4.071%, down 1.4 basis points for the day. “Markets are currently focused on the short-term impact – namely, lower inflation and interest rates falling more quickly,” said Alberto Conca, chief investment officer at LFG+ZEST. Reuters

Housing stocks saw little relief. Shares of Rocket Companies shed 4.7%, settling at $17.14. UWM Holdings slipped 1.4% to $4.56. D.R. Horton dropped 0.6%, Lennar fell 1.2%. The SPDR S&P Homebuilders ETF lost 2.0%. Bond prices held up, nudging the iShares MBS ETF up 0.3%. Financials weighed on the majors as Wall Street broadly declined.

Here’s part of what’s going on: rates might be coming down, but risk appetite is dropping even quicker. Mortgage lenders and builders continue to behave like cyclicals, especially while tariffs and policy uncertainty are steering the tape.

Still, the risks aren’t hard to spot. Should tariff talk spill over into lasting inflation, or if investors begin baking in bigger government deficits, yields could jump—and mortgage rates won’t be far behind. Any slim pickup in affordability might disappear before buyers even lock in a deal.

Tuesday brings the Conference Board’s U.S. consumer confidence numbers, out Feb. 24 at 10:00 a.m. ET. Shifts in this report can jolt rate forecasts if they suggest a change in the growth picture.

Traders are tuning in for any new cues from central bank officials, with Chicago Fed President Austan Goolsbee set to speak Feb. 24 at 7:00 a.m. CT. Markets are adjusting expectations around the timing of potential rate cuts.

Rocket Companies will deliver its fourth-quarter and full-year 2025 earnings after the bell on Feb. 26. The conference call is scheduled for 4:30 p.m. ET, putting mortgage names in focus as analysts watch for any sign that rates below 6% are helping both loan volumes and profitability.

Stock Market Today

  • AMD Shares Surge 13.85% on Strong AI Demand and Analyst Upgrade
    April 25, 2026, 11:10 PM EDT. Shares of Advanced Micro Devices (AMD) jumped 13.85% on Friday after D.A. Davidson analyst Gil Luria upgraded the stock to buy and raised the price target to $375. Luria cited Intel's strong earnings report highlighting robust data center chip sales as a sign of rising demand for high-speed central processing units (CPUs) powering artificial intelligence (AI) agents. The shift towards agentic AI workloads is boosting server CPU demand, benefiting AMD. Luria also noted that with demand outstripping supply, AMD could increase prices on high-performance CPUs, improving margins and profits. Investors await AMD's Q1 financial results and management's conference call on May 5 for more insights on its AI-driven growth prospects.

Latest article

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

ASML Stock’s AI Boom Has a Catch: TSMC Won’t Rush the $410 Million Machine

26 April 2026
ASML shares rose 2.3% in Amsterdam late Friday as the company reported Q1 net sales of €8.8 billion and raised its 2026 sales outlook to up to €40 billion. TSMC, ASML’s top customer, said it would delay adopting ASML’s new High-NA EUV machines, priced at over €350 million each, preferring to extend use of existing tools. ASML aims to deliver at least 60 standard EUV machines in 2026.
Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week
Previous Story

Rackspace (RXT) stock back in play as Palantir AI deal meets earnings week

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop